1. Home
  2. Analysis
  3. Octreotide-acetate
  4. Nicotine

Octreotide acetate and Nicotine drug interactions - a phase IV clinical study of FDA data

Summary:

The phase IV clinical study analyzes what interactions people have when they take Octreotide acetate and Nicotine. It is created by eHealthMe based on reports of 1 person who takes the same drugs from the FDA, and is updated regularly.

What is Octreotide acetate?

Octreotide acetate has active ingredients of octreotide acetate. eHealthMe is studying from 2,449 Octreotide acetate users. Check the latest studies of Octreotide acetate.

What is Nicotine?

Nicotine has active ingredients of nicotine. It is often used in quit smoking. eHealthMe is studying from 20,443 Nicotine users. Check the latest studies of Nicotine.

On Jul, 21, 2026

1 person who takes Octreotide acetate and Nicotine together, and has interactions is studied.

Octreotide acetate and Nicotine drug interactions.

What are the common drug interactions of Octreotide Acetate and Nicotine, by gender? *:

female:

  1. Arterial thrombosis (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system)
  2. Colonic polyp (extra part of colon tissue grow in intestine)
  3. Disease recurrence
  4. Gastric varices
  5. Pancreatitis (inflammation of pancreas)
  6. Splenic infarction (tissue damage of spleen)
  7. Vascular pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)

male:

n/a

What are the common drug interactions of Octreotide Acetate and Nicotine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Arterial thrombosis (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system)
  2. Colonic polyp (extra part of colon tissue grow in intestine)
  3. Disease recurrence
  4. Gastric varices
  5. Pancreatitis (inflammation of pancreas)
  6. Splenic infarction (tissue damage of spleen)
  7. Vascular pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Octreotide acetate and Nicotine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Octreotide acetate and Nicotine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Octreotide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nicotine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Octreotide acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nicotine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on octreotide acetate and nicotine (the active ingredients of Octreotide acetate and Nicotine, respectively), and Octreotide acetate and Nicotine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.